[Basics of the drug therapy for attention deficit hyperactivity disorders in adolescents].
Airaksinen
Eila
E
Kuopion yliopisto, lastenklinikka Kuvelammentie 24 70800 Kuopio. eila.airaksinen@uku.fi
Airaksinen
Mauno M
MM
D000293:Adolescent; D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use; D009638:Norepinephrine / Q000378:metabolism; D016896:Treatment Outcome
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine